Attachment_2_-_Small_Business_Subcontracting_Plan.docx.pdf

This document provides details on a federal contract opportunity for medical countermeasures for pandemic influenza preparedness and response. The Department of Health and Human Services through the Biomedical Advanced Research and Development Authority Acquisition Management, Contracts and Grants intends to issue a Request for Proposal for products and services including cGMP influenza vaccine master and working seed lots, investigational and commercial scale bulk vaccine lots, adjuvant bulk lots, formulation and filling, storage and stability, shipping, candidate vaccine viruses, potency reagents and standards, analytical testing, non-clinical and clinical studies, disposal, and additional reporting. Eligible offerors must produce influenza vaccines and have a US license or demonstrated vaccine development experience. The base period of performance is three years with two optional one-year extensions. Interested parties should monitor the Federal Business Opportunities website for release of the RFP on or about January 12, 2015, with proposals due February 20, 2015 and anticipated multiple awards by July 2015.